< Back to previous page
Researcher
Ghislain Opdenakker
- Disciplines:Immunology
Affiliations
- Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 2001 → Today - Molecular Immunology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 25
- Regulation and function of immune cell proteases in multiple sclerosis.From1 Jan 2021 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Study and selective targeting of monomeric and trimeric gelatinase B/ MMP-9From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Functional analysis of active alpha-2-macroglobulin/protease complexes and their potential applications in protease-driven diseasesFrom1 Oct 2019 → 30 Sep 2022Funding: FWO fellowships
- Immunomodulation of wound healingFrom1 Jun 2019 → 4 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Functional subset definition and molecular regulation of neutrophils and natural killer cells in infection and inflammation.From1 Oct 2017 → 30 Sep 2023Funding: BOF - projects, Fund Recuperation Fiscal Exemption
- Role of MMP-9 in systemic lupus erythematosus.From1 Oct 2016 → 30 Sep 2019Funding: FWO fellowships
- Post-translational modifications and multiple sclerosis: assessment of proteolysis and citrullination as disease-modifiers in animal models of neuroinflammation.From1 Jan 2016 → 31 Dec 2017Funding: Nonprofit institution or equivalents
- Novel posttranslational modifications of gelatinase B/matrix metalloproteinase-9From1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Wound healing in diabetes with innate immune molecules and cellsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 274
- Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage(2024)
Authors: Jennifer Vandooren, Ghislain Opdenakker
- Immunomodulation of wound healing(2023)
Authors: Rafaela Vaz Sousa Pereira, Ghislain Opdenakker, Patrick Matthys, Jan Vranckx
- CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy(2023)
Authors: Luna Dillemans, Gert De Hertogh, Ghislain Opdenakker, Sofie Struyf
- Fast and furious: The neutrophil and its armamentarium in health and disease(2023)
Authors: Mieke Gouwy, Lien De Somer, Ghislain Opdenakker, Paul Proost
Pages: 1537 - 1606 - Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders(2023)
Authors: Gert De Hertogh, Sara Salama, Ghislain Opdenakker, Sofie Struyf
- Matrix metalloproteinases in arthritis: towards precision medicine(2023)
Authors: Jo Van Damme, Paul Proost, Ghislain Opdenakker
Pages: 363 - 377 - Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing(2023)
Authors: Mostafa Ezeldeen, Jennifer Vandooren, Jan Vranckx, Patrick Matthys, Ghislain Opdenakker
- Antibodies as tools in cytokine discovery and usage for diagnosis and therapy of inflammatory diseases.(2023)
Authors: Jo Van Damme, Ghislain Opdenakker, Sofie Struyf
Pages: 1 - 9 - Therapeutic window of opportunity in the acute uveitic phase of Vogt-Koyanagi-Harada disease: Prevention of late autoimmune complications by early intervention(2023)
Authors: Ghislain Opdenakker
Pages: E236 - E245 - How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities?(2022)
Authors: Ghislain Opdenakker, Séverine Vermeire